Literature DB >> 15764677

Arginine vasopressin reduces intestinal oxygen supply and mucosal tissue oxygen tension.

H Knotzer1, W Pajk, S Maier, R Ladurner, A Kleinsasser, V Wenzel, M W Dünser, H Ulmer, W R Hasibeder.   

Abstract

We investigated intestinal oxygen supply and mucosal tissue PO2 during administration of increasing dosages of continuously infused arginine vasopressin (AVP) in an autoperfused, innervated jejunal segments in anesthetized pigs. Mucosal tissue PO2 was measured by employing two Clark-type surface oxygen electrodes. Oxygen saturation of jejunal microvascular hemoglobin was determined by tissue reflectance spectrophotometry. Microvascular blood flow was assessed by laser-Doppler velocimetry. Systemic hemodynamic variables, mesenteric venous and systemic acid-base and blood gas variables, and lactate measurements were recorded. Measurements were performed at baseline and at 20-min intervals during incremental AVP infusion (n = 8; 0.007, 0.014, 0.029, 0.057, 0.114, and 0.229 IU.kg(-1).h(-1), respectively) or infusion of saline (n=8). AVP infusion led to a significant (P < .05), dose-dependent decrease in cardiac index (from 121 +/- 31 to 77 +/- 27 ml.kg(-1).min(-1) at 0.229 IU.kg(-1).h(-1)) and systemic oxygen delivery (from 14 +/- 3 to 9 +/- 3 ml.kg(-1).min(-1) at 0.229 IU.kg(-1).h(-1)) concomitant with an increase in systemic oxygen extraction ratio (from 31 +/- 4 to 48 +/- 10%). AVP decreased microvascular blood flow (from 133 +/- 47 to 82 +/- 35 perfusion units at 0.114 IU.kg(-1).h(-1)), mucosal tissue PO2 (from 26 +/- 7 to 7 +/- 2 mmHg at 0.229 IU.kg(-1).h(-1)), and microvascular hemoglobin oxygen saturation (from 51 +/- 9 to 26 +/- 12% at 0.229 IU.kg(-1).h(-1)) without a significant increase in mesenteric venous lactate concentration (2.3 +/- 0.8 vs. 3.4 +/- 0.7 mmol/l). We conclude that continuously infused AVP decreases intestinal oxygen supply and mucosal tissue PO2 due to a reduction in microvascular blood flow and due to the special vascular supply in the jejunal mucosa in a dose-dependent manner in pigs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764677     DOI: 10.1152/ajpheart.01235.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

1.  Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ.

Authors:  P Asfar; P Radermacher; B Hauser
Journal:  Intensive Care Med       Date:  2005-11-18       Impact factor: 17.440

2.  Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model.

Authors:  Hans Knotzer; Stephan Maier; Martin W Dünser; Walter R Hasibeder; Hans Hausdorfer; Julia Brandner; Christian Torgersen; Hanno Ulmer; Barbara Friesenecker; Claudia Iannetti; Werner Pajk
Journal:  Intensive Care Med       Date:  2005-11-18       Impact factor: 17.440

Review 3.  From system to organ to cell: oxygenation and perfusion measurement in anesthesia and critical care.

Authors:  Patrick Schober; Lothar A Schwarte
Journal:  J Clin Monit Comput       Date:  2012-03-22       Impact factor: 2.502

Review 4.  [Microcirculation of intensive care patients. From the physiology to the bedside].

Authors:  H Knotzer; W Hasibeder
Journal:  Anaesthesist       Date:  2008-02       Impact factor: 1.041

5.  Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.

Authors:  Tal Kopel; Marie-Reine Losser; Valérie Faivre; Didier Payen
Journal:  Intensive Care Med       Date:  2008-03-26       Impact factor: 17.440

6.  Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis.

Authors:  Werner Ribitsch; Daniel Schneditz; Casper F M Franssen; Gernot Schilcher; Vanessa Stadlbauer; Jörg H Horina; Alexander R Rosenkranz
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

7.  Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow.

Authors:  Vladimir Krejci; Luzius B Hiltebrand; Stephan M Jakob; Jukka Takala; Gisli H Sigurdsson
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

8.  Terlipressin protects intestinal epithelial cells against oxygen-glucose deprivation/re-oxygenation injury via the phosphatidylinositol 3-kinase pathway.

Authors:  Zi-Meng Liu; Xu-Yu Zhang; Juan Chen; Jian-Tong Shen; Zhi-Yi Jiang; Xiang-Dong Guan
Journal:  Exp Ther Med       Date:  2017-05-23       Impact factor: 2.447

9.  Exogenous vasopressin dose-dependently modulates gastric microcirculatory oxygenation in dogs via V1A receptor.

Authors:  Richard Truse; Steven Grewe; Anna Herminghaus; Jan Schulz; Andreas P M Weber; Tabea Mettler-Altmann; Inge Bauer; Olaf Picker; Christian Vollmer
Journal:  Crit Care       Date:  2019-11-12       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.